Association between serum vitamin D levels and insulin resistance among adults
DOI:
https://doi.org/10.18203/2320-6012.ijrms20261693Keywords:
Glucose metabolism, HOMA-IR, Insulin resistance, Type 2 diabetes mellitus, Vitamin D deficiencyAbstract
Background: Vitamin D is increasingly recognized for its role beyond bone metabolism, particularly in glucose homeostasis and insulin sensitivity. Deficiency of vitamin D has been implicated in the development of insulin resistance, a key pathophysiological mechanism underlying type 2 diabetes mellitus. Several studies have demonstrated a relationship between low Vitamin D levels and metabolic dysfunction. This study aimed to assess the association between serum vitamin D levels and insulin resistance among adults.
Methods: A hospital-based cross-sectional study was conducted among 120 adults aged 20-60 years. Serum 25-hydroxyvitamin D, fasting blood glucose, and fasting insulin levels were measured. Insulin resistance was calculated using HOMA-IR. Participants were categorized into vitamin D deficient and sufficient groups. Statistical analysis included descriptive statistics, independent t-test, Pearson correlation, chi-square test, and regression analysis.
Results: Vitamin D deficiency was observed in 56.7% of participants. Individuals with vitamin D deficiency had significantly higher fasting insulin and HOMA-IR values. A significant inverse correlation was found between vitamin D levels and insulin resistance (r = -0.52, p<0.001), consistent with previous studies. Regression analysis identified vitamin D as an independent predictor of insulin resistance.
Conclusions: Vitamin D deficiency is significantly associated with increased insulin resistance. Early identification and correction of Vitamin D deficiency may help reduce metabolic risk.
References
Chiu KC, Chu A, Go VLW, Saad MF. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr. 2004;79(5):820-5.
Pittas AG, Lau J, Hu FB, Dawson-Hughes B. The role of Vitamin D and calcium in type 2 diabetes. J Clin Endocrinol Metab. 2007;92(6):2017-29.
George PS, Pearson ER, Witham MD. Effect of Vitamin D supplementation on glycaemic control. Diabet Med. 2012;29(8):e142-50.
Kayaniyil S, Vieth R, Retnakaran R, Knight JA, Qi Y, Gerstein HC, et al. Association of vitamin D with insulin resistance and β-cell dysfunction in subjects at risk for type 2 diabetes. Diabetes Care. 2010;33(6):1379-81.
Scragg R, Sowers M, Bell C. Serum Vitamin D and diabetes. Diabetes Care. 2004;27(12):2813-8.
Muscogiuri G, et al. Vitamin D and insulin resistance: a systematic review. Nutrients. 2020;12(6):1641.
Ford ES, Zhao G, Li C, Pearson WS. Vitamin D and metabolic syndrome. J Diabetes. 2009;1(4):296-303.
Maestro B, Dávila N, Carranza MC, Calle C. Vitamin D and insulin receptor gene. J Steroid Biochem Mol Biol. 2003;84(2-3):223-30.
Alvarez JA, Ashraf A. Role of vitamin D in insulin secretion and insulin sensitivity for glucose homeostasis. Int J Endocrinol. 2010;2010(1):351385.
Palomer X, González‐Clemente JM, Blanco‐Vaca F, Mauricio D. Role of vitamin D in the pathogenesis of type 2 diabetes mellitus. Diabetes Obes Metab. 2008;10(3):185-97.
Mitri J, Muraru MD, Pittas AG. Vitamin D and type 2 diabetes: a systematic review. Eur J Clin Nutr. 2011;65(9):1005-15.
Muscogiuri G, Barrea L, Somma CD, Laudisio D, Salzano C, Pugliese G, et al. Sex differences of vitamin D status across BMI classes: an observational prospective cohort study. Nutrients. 2019;11(12):3034.
Downloads
Published
How to Cite
Issue
Section
